Pervasis - Pioneering regenerative cell-based therapies and devices to treat serious illnesses
Company Technology Clinical Research and Development News Contact
News
Press Releases
Pervasis in the News
Publications
Clinical Study Updates

Press Releases

2008

August 5, 2008
Pervasis Therapeutics Appoints Frank Litvack, M.D., Former CEO of Conor Medsystems, to its Board of DirectorsPDF ]

January 15, 2008
Pervasis Therapeutics Closes Additional $9.75 Million in FinancingPDF ]

[ back to top ]


2007

September 17, 2007
Pervasis Therapeutics announces New Animal Study Results Supporting Vascugel™ in Promoting Healing after Blood Vessel InjuryPDF ]

August 13, 2007
Pervasis Therapeutics Successfully Completes Enrollment for Vascugel™ Phase II Clinical TrialsPDF ]

May 15, 2007
Pervasis Therapeutics, Inc. Named to Red Herring 100, Spring 2007PDF ]

April 17, 2007
Pervasis Therapeutics Selected as a Finalist for the Red Herring 100 North American 2007PDF ]

March 19, 2007
Pervasis Therapeutics Launches Enrollment for Two Phase II Clinical Trials for VascugelPDF ]

[ back to top ]


2006

November 15, 2006
Pervasis Therapeutics Announces Successful Initial Safety Results of Phase I TrialsPDF ]

September 27, 2006
Pervasis Therapeutics' Vascugel Initiates U.S. Clinical TrialsPDF ]

[ back to top ]


2005

September 30, 2005
Pervasis Therapeutics Closes 12 Million Series B FinancingPDF ]

September 30, 2005
Pervasis Therapeutics Expands TeamPDF ]

[ back to top ]

Copyright 2008 Pervasis Therapeutics, Inc.  |  design by Digizyme